ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aaron Carman

Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA

Biography

Dr. Aaron J. Carman Ph.D. Director, Alzheimer’s Drug Discovery Foundation InVitro Cell Research, LLC, New York City, United States, in the past Senior Program Manager and Assistant Director, Aging and Alzheimer's Prevention in 2014-2015. Works on Brain diseases.



   



 
Publications

Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention

Maintenance of cellular homeostasis is regulated by the molecular chaperones. Under pathogenic conditions, aberrant proteins are triaged by the chaperone network. These aberrant proteins, known as “clients,” have major roles in the pathogenesis of numerous neurological disorders, including tau in Alzheimer’s disease, α-synuc... Read More»

Aaron Carman, Sarah Kishinevsky, John Koren III, Wenjie Lou and Gabriela Chiosis

Review Article: J Alzheimers Dis Parkinsonism 2013, S10-007

DOI: 10.4172/2161-0460.S10-007

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

https://bahigox.fun/ https://bahisjet.fun/ https://bahsegel.fun/ https://betboo.fun/ https://betdoksan.xyz/ https://betebetgiris.xyz/ https://betexper.fun/ https://betgram.fun/ https://betkanyon.fun/ https://betkolik.fun/
Top